Clinical Study

American Visceral Leishmaniasis: Factors Associated with Lethality in the State of São Paulo, Brazil

Table 4

Final model of factors associated with VL lethality, state of Sao Paulo, 1999–2005 (multivariate analysis).

Clinical outcome
VariableDeathCuredTotalOR (95% CI)* 𝑃 value**
𝑛 = 5 3 𝑛 = 3 2 3 𝑛 = 3 7 6

High total bilirubin
 Total Bilirubin ≥ 2.0 g/dL136197.36 (1.65–32.76)<0.0001
Severe anemia
 Hemoglobin ≤ 5.0 g/dL713204.56 (1.17–17.48)<0.0001
Antimicrobial agents3459935.76 (2.27–14.64)<0.0001
Age ≥ 50 years28174529.54 (10.6–82.6)
Length of illness (days)
 Fever >60 days1326396.23 (2.05–18.92)<0.0001
Hemorrhagic manifestations1822402.62 (0.93–7.4)0.0001
Cardiac abnormality910194.73 (1.3–17.23)<0.0001
Diarrhea2052722.76 (1.03–7.43)<0.0001

*Odds ratio (95% confidence interval). **Likelihood ratio.